Solid Biosciences Stock Rated Overweight by Cantor Fitzgerald

Cantor Fitzgerald has reiterated its Overweight rating on Solid Biosciences. This reappraisal often indicates a favorable outlook on the company's future performance in the market. Such analyst ratings can influence investor decisions and potentially lead to price changes. Solid Biosciences could see increased interest from investors due to this endorsement and potential future developments.